Top Markets
#1 Smilek to the Bank Smilek to the Bank +50.56%
#2 Purr Purr +48.10%
#3 Pons Pons +21.27%
#4 Non-Playable Coin Non-Playable Coin +21.00%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +20.47%
#6 ApeX ApeX +20.21%
#7 OriginTrail OriginTrail +20.09%
#8 龙虾 (Lobster) 龙虾 (Lobster) +19.97%
#9 Zora Zora +16.31%
#10 Morpho Morpho +16.16%
Coin of the day
Smilek to the Bank Smilek to the Bank
Settings
Language
ENGLISH
Currency
USD
Theme
BioGend Therapeutics Co., Ltd. BioGend Therapeutics Co., Ltd.

BioGend Therapeutics Co., Ltd.

6733
Rank in Stocks #21371
This company specializes in the development of innovative regenerative... This company specializes in the development of innovative regenerative bio-orthopedic products. Its current pipeline includes BiG-001 and BiG-006, both of which are osteoinductive bone graft substitutes. Additionally, it is advancing BiG-009, an autologous cartilage repair system. Established in 2016, the firm's operations are based in Taipei, Taiwan.
Share Price
$0.81882497
Last synced: 2026-08-21
Market Cap
$108.85M
Change (1 day)
0.39%
Change (1 year)
-38.35%
Country
TW
Trade BioGend Therapeutics Co., Ltd. (6733)

Category

Healthcare
Stock split history for BioGend Therapeutics Co., Ltd. (6733)
BioGend Therapeutics Co., Ltd. stock (symbol: 6733) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 23, 2026.
One 6733 share bought prior to Aug 23, 2026 would equal to 0 6733 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH